Clinical Trial Update: Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a biological therapy after chemotherapy in patients with relapsed or refractory non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Non-hodgkin Lymphoma

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED